Sex: F
Vaccine: COVID19
Symptoms: Incorrect route of product administration, Nausea
Clinical narrative: Nauseous; the injection went straight under the skin/subcutaneous injection; This is a spontaneous report received from a Consumer or other non HCP from medical information team.  An 88-year-old female patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) subcutaneous for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Pfizer covid-19 vaccine (Dose 4 (BOOSTER), single, a year ago), for COVID-19 immunisation; Pfizer covid-19 vaccine (Dose 3 (Booster), single, Manufacturer unknown), for COVID-19 immunisation; Pfizer covid-19 vaccine (Dose 2, single, Manufacturer unknown), for COVID-19 immunisation; Pfizer covid-19 vaccine (Dose 1, single, Manufacturer unknown), for COVID-19 immunisation. The following information was reported: NAUSEA (non-serious), outcome "unknown", described as "Nauseous"; INCORRECT ROUTE OF PRODUCT ADMINISTRATION (non-serious), outcome "unknown", described as "the injection went straight under the skin/subcutaneous injection".  Additional information: the person that injected the Comirnaty vaccine pinched the skin and it looked as if he administered it. He pinched it and looked like it was barely going under the skin at an angle was not parallel because it would be like scraping, but probably a 190 degree angle. The brochure said to administer in the muscle. The reporter asked the person administering about subcutaneous injection and the person said, yes, it's for subcutaneous injection, he asked the person to show him where it says that, and he wasn't able to show that information. The reporter spoke to the pharmacist directly, she explained what a subcutaneous needle looks like and it's not even a quarter inch. This needle being as long as it is, what worries him was the angle was horizontal. The pharmacist said it wouldn't change the effect receiving the medication subcutaneously, the body will absorb it. The reporter had it done before with his father who is 95 years old and mother 88 years old, she always take them to get boosters, they have pinched before and administered perpendicularly. When he get it, they administer it usually about 85 to 75 degree angle. The reporter would like to know when will be the soonest they could get a booster,  if the vaccine was valid. This dose they received was the first dose of the Comirnaty vaccine 2023/2024 formula. The dose they received before this one of the Pfizer covid 19 vaccine was a year before this one they just received. They have had 4 doses, they have been postponing getting the new formulation until now. The patient has no discomfort, not having any effects at the injection site, which they usually feel something deep down at the injection site, even he felt something the day of the injection and maybe a day after, but the patient don't feel anything, which the reporter think as strange. They were pressing over the bandaid and they don't feel anything. The reported then, hang up he states he has to go because his mother (patient) is feeling nauseous.  The information on the batch/lot number for BNT162b2 omi xbb.1.5 will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202400083600 same reporter/product/event, different patient;US-PFIZER INC-202400083645 same reporter/product/event, different patient;